why choose us

First received: September 15, 2023

Clinical Trial: The Gut Microbiome and Immunotherapy Response in Solid Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer

Study Type: OBSERVATIONAL


Official Title: The Gut Microbiome and Immunotherapy Response in Solid Cancers

Brief Summary: The aim of this study is characterize the gastrointestinal microbiomes of patient with solid cancer undergoing standard of care treatment with programmed cell death protein 1 (PD-1) /programmed cell death ligand (PD-L1) blockade.

Read more